Floatz logo

Cyclosporin A

Small Intestine Lymphoma

National Cancer Institute (NCI)protein_peptidePhase 2Dormant
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Small Intestine Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
Case Comprehensive Cancer Center
Phase 2BBB
Cyclophosphamide
University of Chicago
Phase 2BBB
Rituximab
Mayo Clinic
Phase 2BBB
Etoposide
Fred Hutchinson Cancer Center
Phase 2BBB
Dexasone
Mayo Clinic
Phase 2BBB

View all 50 →

Same molecule, other indications

Cyclosporin A is also rated in:

non-Hodgkin lymphomaActive
BBB
Indicative · Phase 3
76 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmActive
BBB
Indicative · Phase 3
76 / 100
View asset →
disease related to transplantationActive
BBB
Indicative · Phase 4
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →